Justin Starzyk

Justin is an Operating Advisor of Cedar Investors and joined the firm in 2018. He currently serves as the CEO and Co-Founder of a Redesign Health portfolio company and led Cedar Dental as Executive Chairman from 2019 through 2021. Previously, Justin was a senior executive at DaVita, where he co-founded and ran MSO operations for DaVita Health Solutions, a large medical group at risk for complex, chronically ill patients. Prior to that at DaVita, he started and ran another business managing high-risk chronic kidney disease patients for multispecialty groups, was Chief of Staff to the CEO of Kidney Care (an $11b business), and was Co-Head of Growth for all of DaVita's US Kidney Care business (100 de novos annually). Prior to DaVita, Justin worked as a consultant with Bain & Company, as an investment banker with JPMorgan, and as a biochemical engineer with Abbott Labs / AbbVie. He currently serves on the board of Vail Health. Justin holds a BS in Chemical Engineering from Northwestern University and an MBA from the Kellogg School of Management.